Corti Stab
Natural health product licensed in Canada
- Other names
- Bonne Nuit
- Licence holder
- Shop Santé Inc.
- NPN or DIN-HM
- 80097769
- Status
- Active licence
- Licence date
- 23 March 2020
- Revision date
- 23 September 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine C Source : Acide ascorbique | 34 mg | 68,000 µg |
Non-medicinal ingredients
Hypromellose, Dioxyde de silicium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps to temporarily promote relaxation. Helps to re-set the body's sleep-wake cycle (aspect of the circadian rhythm). Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule (e.g. shift-work and jet lag). Helps to speed up/ reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people who fall asleep slowly/with delayed sleep phase disorder. Contributes to maintaining general health. Source of/Provides (an) antioxidant(s). Helps to maintain the body's ability to metabolize nutrients.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Stop use if allergy occurs or if you experience headache, confusion, or nausea. When using this product avoid driving or using machinery for 5 hours. When using this product exercise caution if you drive or use machinery as you may experience drowsiness.
- Contre-indications
Do not use with alcohol. Do not use this product if you are pregnant or breastfeeding.
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. When using this product avoid taking with alcohol or products that cause drowsiness. Consult a health care practitioner prior to use if you are taking medications for seizure, blood pressure, to suppress the immune system (immunosuppressive medications), to affect mental state or increase sedation, steroids or blood thinners. Ask a health care practitioner before use if you have cardiovascular, immune, liver or kidney disease, seizure disorder, asthma or diabetes. Ask a health care practitioner if sleeplessness persists for more than 4 weeks (chronic insomnia).
Source
Official Health Canada record, licence 80097769
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.